. Thus, RelB complexes robustly inhibit ERα expression and activity. 2
RelB induces expression of the zinc finger repressor protein Blimp1. Since RelB has a 3 transactivation domain and has not been shown to function itself directly as an inhibitor of 4 transcription, we tested the hypothesis that it controls the expression of an intermediate negative 5
regulatory factor that represses ERα. TransFac analysis (at 80% certainty) of promoter B 6 sequences identified 3 putative binding sites for Blimp1, a master regulator of B and T cell 7 development. The Zn finger protein Blimp1, which functions as a repressor of key regulatory 8 genes in these cells, is expressed from the gene termed PRDM1 (human) or Blimp1 (mouse) (24). 9
Since expression of Blimp1 has not been reported in epithelial cells, we first tested for 10 endogenous Blimp1 protein in nuclear extracts of human and mouse breast cancer cells. 11
Substantial Blimp1 levels were detectable in ERα negative Hs578T human breast cancer cells, 12 and more moderate levels in ERα negative MDA-MB-231 cells ( Fig. 2A) . Very low, but 13 detectable Blimp1 levels were seen with ERα positive ZR-75, MCF-7, T47D, and BT474 human 14 breast cancer cell lines (better seen on darker exposures and see Next we sought to test whether the ERα promoter is indeed repressed by ectopic Blimp1 16 expression and to localize the functional Blimp1 binding element(s). An ~4-fold reduction in 17 activity of an ERα proB construct (Fig. 2J) , which contains all three putative Blimp1 binding 18 sites, was seen with ectopic Blimp1 expression in co-transfection analysis in MCF-7 cells 19 compared to EV DNA. The three Blimp1 sites all contain the core GAAA sequence, but differ in 20 surrounding sequencing (see Materials and Methods). To identify the functional sites, 21 competition and supershift EMSA were performed using nuclear extracts of ZR-75 cells 22 ectopically expressing Blimp1 protein or control EV DNA and an oligonucleotide containing the 23 Blimp1 binding site of the c-MYC gene as probe. Putative site 2, but not sites 1 or 3, competed 1 well for binding to the c-MYC Blimp1 site (Fig. 3A) . When used as a probe, the putative site 2 2 oligonucleotide effectively bound Blimp1 protein (Fig. 3B) , as judged by supershift EMSA (Fig.  3   3C ), confirming this site is a bona fide Blimp1 element. The position of this confirmed Blimp1 4 site is indicated on the map in Fig. 3D . ChIP analysis confirmed intracellular binding of Blimp1 5
following ectopic expression to the ERα promoter B region containing the element in MCF-7 6 cells ( Fig. 3E, upper panels) . Furthermore, ChIP analysis in Hs578T cells, which expressed the 7 highest levels of Blimp1, confirmed binding of endogenous Blimp1 to this ERα promoter B 8 region (Fig. 3E , lower panels). 9
To assess the functional role of the low endogenous levels of Blimp1 in the ERα positive 10 lines, a dominant negative form of Blimp1, termed TBlimp or dnBlimp (1), which contains only 11 the DNA binding domain, was used. Ectopic expression of the dnBlimp caused an increase in 12
ERα protein (Fig. 3F ), indicating that endogenous Blimp1 represses ERα in these lines. 13
Consistently, as seen in Figure 4A below, knockdown of Blimp1 levels using an siRNA strategy 14 in NF639 cells induced ERα protein levels. Conversely, ectopic Blimp1 expression substantially 15 reduced ERα expression in ZR-75 and MCF-7 cells (Fig. 3G) , indicating it can repress the 16 endogenous ERα gene in both lines. Blimp1 expression also led to reduced ERα RNA levels in 17 ZR-75 cells, while inhibition of Blimp1 activity with the dnBlimp led to their induction (Fig.  18   3H ). Of note, expression of the dnBlimp ablated the decrease in ERα expression induced by 19 ectopic RelB in MCF7 cells (Fig. 3I) ERα levels (see Fig. 3G above), substantially increased migration (Fig. 4B, left panel) , and 10 commensurately decreased levels of E-cadherin and γ-catenin (Fig. 4B, right panel) . We next 11 assessed the role of ERα in the ability of Blimp1 to promote a more migratory phenotype. 12
Expression of ERα prevented the increased ability of ZR-75 cells to migrate resulting from 13 Blimp1 expression (3.1-fold vs 1.1-fold) (Fig. 4C, left panel) as well as the decrease in E-14 cadherin and γ-catenin induced by Blimp1 (Fig. 4C, right panel) . Lastly, dnBlimp expression 15 induced the levels of E-cadherin expression in ZR-75 and MCF-7 cells, and these increases were 16 prevented upon knockdown of ERα using siERα RNA (Fig. 4D) For example, knockdown of Bcl-2 in Hs578T cells impaired the ability of the cells to migrate, 22 whereas stable ectopic expression of Bcl-2 in MCF-7 cells (MCF-7/Bcl-2 vs MCF-7/pBABE 23 stable cells) was sufficient to promote a more migratory phenotype via decreasing E-cadherin 1 levels (56). Thus, we tested the hypothesis that Bcl-2 mediates the induction of Blimp1 by RelB. 2
Knockdown of Bcl-2 with the Bcl2 shRNA in NF639 cells led to increased ERα levels (Fig 5A,  3 left panel), whereas Bcl-2 overexpression decreased ERα level in ZR-75 and MCF-7 cells (Fig  4   5A , right panel), indicating Bcl-2 can negatively regulate ERα expression. Consistently, 5 knockdown of Bcl-2 levels led to downregulation of Blimp1 protein and Blimp1 RNA levels in 6 NF639 cells (Fig. 5B, upper panels) , whereas ectopic Bcl-2 expression robustly induced their 7 levels in these cells (Fig. 5B , lower panels). Similarly Bcl-2 led to substantial increases in the 8 levels of PRDM1 RNA (Fig. 5C , upper panels) and Blimp1 protein expression (Fig. 5C , lower 9 panels) in both ZR-75 and MCF-7 cells, while ectopic BCL2 shRNA, which inhibited RelB/p52-10 mediated induction of Bcl-2 (56), prevented the induction of Blimp1 by RelB/p52 in ZR-75 cells 11 as well as the reduction of ERα levels (data not shown). Lastly, the dnBlimp1 robustly impaired 12 the previously observed ability of Bcl-2 to enhance migration of MCF-7 cells in MCF-7/Bcl-2 13 cells ( Fig 5D) . 14 WT Bcl-2, which has been shown to interact with and activate Ras in the mitochondria of 15 cells, leads to the induction of NF-κB and AP-1, whereas a Bcl-2 14G mutant unable to associate 16 with Ras is functionally inactive (7, 15, 35) . Notably, Ohkubo and coworkers identified an AP-1 17 element upstream of the Blimp1 promoter (34) leading us to hypothesize a role for Bcl-2/Ras 18 interaction in the activation of Blimp1. As a first test, we compared the effects of the wild type 19 of Ras, whereas, control rabbit IgG protein did not (Fig. 6A, left panel) . Furthermore, co-3 immunoprecipitation analysis of endogenous proteins in NF639 cell extracts similarly detected 4 association between endogenous Ras and Bcl-2 (Fig. 6A, right panels) . Confocal microscopy 5 confirmed the partial association of transfected Ras-GFP with Bcl-2 in the mitochondria of ZR-6 75 cells (Fig. 6B , and see projection images in Supplementary Information, Fig. S1 ). 7
Interestingly, ectopic Bcl-2 expression led to enhanced membrane and reduced cytosolic 8 localization of endogenous Ras protein in ZR-75 and MCF-7 cells (Fig. 6C) . To evaluate the 9 requirement for Ras membrane localization, we compared the effects on ERα levels of 10 expression of Ras WT vs a Ras C186S mutant, which is unable to localize to the membrane (5, 11 8). The Ras C186S mutant, which interacts with Bcl-2 as well as Ras WT (data not shown), was 12 unable to reduce ERα levels or to induce Blimp1 expression in contrast to findings with Ras WT 13 (Fig. 6D) . Furthermore, Ras C186S prevented the reduction in ERα levels mediated by Bcl-2 14 (Fig. 6E) and activation of the PRDM1 promoter (Fig. 6F) , suggesting it functions as a dominant 15 negative variant. Lastly, we tested the role of mitochondrial localization using two Bcl-2 16 mutants: Bcl-acta, which localizes to the mitochondria, and Bcl-nt, which predominantly 17 localizes to the cytoplasm (64). Whereas Bcl-acta and Bcl-2 WT cooperated with Ras to induce 18 the PRDM1 promoter, the Bcl-nt was unable to induce its activity (Fig. 6G) , consistent with an 19 important role for co-localization in the mitochondria. 20
To test whether Ras signaling is sufficient to induce Blimp1 expression, constitutively 21 active Ras was ectopically expressed in ZR-75 and MCF-7 cells; potent upregulation of Blimp1 22 was observed (Fig. 7A) . We next assessed data publicly available on microarray gene expression 23 profiling of primary human mammary epithelial cells following transformation with various 1 genes. Consistent with the data presented above, a significant induction of PRDM1 mRNA 2 expression was detected upon expression of activated H-Ras vs GFP (P = 1.0e -7 ), but not with 3 E2F3, activated β-catenin, c-Myc or c-Src (2) (Fig. 7B) . A significant difference was also 4 observed in PRDM1 mRNA levels between the means of the H-Ras group vs all others combined 5 (P = 1.7e -10 ). Lastly, we sought to elucidate the role of Ras on cell migration induced by Bcl-2 in 6 MCF-7 cells using the dominant negative function of the Ras C186S mutant. Ras C186S mutant, 7
but not Ras WT, inhibited the Bcl-2-mediated decrease in E-cadherin and ERα levels ( 
